Literature DB >> 17244518

Nociceptive flexion reflex and pain rating responses during endogenous opiate blockade with naltrexone in healthy young adults.

Christopher R France1, Mustafa al'Absi, Christopher Ring, Janis L France, Angie Harju, Lorentz E Wittmers.   

Abstract

The effect of opioid blockade on nociceptive flexion reflex (NFR) activity and subjective pain ratings was examined in 151 healthy young men and women. Using a within-subjects design, NFR threshold was assessed on 2 days after administration of either placebo or a 50mg dose of naltrexone. Electrocutaneous pain threshold and tolerance levels were measured after NFR threshold assessment on each day. Results indicated that administration of naltrexone was consistently associated with hypoalgesic responding. Specifically, participants exhibited lower levels of NFR activity and reported lower pain ratings for electrocutaneous stimulation delivered at pain threshold and tolerance levels following administration of naltrexone as compared to placebo. These findings indicate that opiate blockade using the current standard dose may elicit hypoalgesia. A potential moderating effect of dose of opiate-blockade medication and level of endogenous opioid activation should be carefully examined in future research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17244518      PMCID: PMC1892310          DOI: 10.1016/j.biopsycho.2006.12.005

Source DB:  PubMed          Journal:  Biol Psychol        ISSN: 0301-0511            Impact factor:   3.251


  51 in total

1.  Hormonal and other effects of naltrexone in normal men.

Authors:  J Volavka; A Mallya; J Bauman; J Pevnick; D Cho; D Reker; B James; R Dornbush
Journal:  Adv Exp Med Biol       Date:  1979       Impact factor: 2.622

2.  Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain.

Authors:  J D Levine; N C Gordon; H L Fields
Journal:  Nature       Date:  1979-04-19       Impact factor: 49.962

3.  Opioid antagonists, endogenous ligands and nociception.

Authors:  J J Jacob; K Ramabadran
Journal:  Eur J Pharmacol       Date:  1977-12-15       Impact factor: 4.432

4.  Naloxone decreases diurnal variation in pain sensitivity and somatosensory evoked potentials.

Authors:  G C Davis; M S Buchsbaum; W E Bunney
Journal:  Life Sci       Date:  1978-10-09       Impact factor: 5.037

5.  Analgesia and hyperalgesia produced in the rat by intrathecal naloxone.

Authors:  C J Woolf
Journal:  Brain Res       Date:  1980-05-12       Impact factor: 3.252

6.  Dose-dependent analgesic and hyperalgesic effects of systemic naloxone in arthritic rats.

Authors:  V Kayser; G Guilbaud
Journal:  Brain Res       Date:  1981-12-07       Impact factor: 3.252

7.  Endogenous opiates and nociception: a possible functional role in both pain inhibition and detection as revealed by intrathecal naloxone.

Authors:  A H Dickenson; D Le Bars; J M Besson
Journal:  Neurosci Lett       Date:  1981-07-02       Impact factor: 3.046

8.  Endorphins: naloxone fails to alter experimental pain or mood in humans.

Authors:  P Grevert; A Goldstein
Journal:  Science       Date:  1978-03-10       Impact factor: 47.728

9.  Effects of naloxone on hemodynamic and sympathetic nerve responses to pain in normotensive vs. borderline hypertensive men.

Authors:  H P Schobel; H O Handwerker; R E Schmieder; K Heusser; P Dominiak; F C Luft
Journal:  J Auton Nerv Syst       Date:  1998-03-03

10.  Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes.

Authors:  J C Willer; H Dehen; J Cambier
Journal:  Science       Date:  1981-05-08       Impact factor: 47.728

View more
  7 in total

1.  Reduction of conditioned pain modulation in humans by naltrexone: an exploratory study of the effects of pain catastrophizing.

Authors:  Christopher D King; Burel Goodin; Lindsay L Kindler; Robert M Caudle; Robert R Edwards; Nikolaus Gravenstein; Joseph L Riley; Roger B Fillingim
Journal:  J Behav Med       Date:  2012-04-26

Review 2.  Stress and Addiction: When a Robust Stress Response Indicates Resiliency.

Authors:  Mustafa alʼAbsi
Journal:  Psychosom Med       Date:  2018-01       Impact factor: 4.312

3.  Endogenous opioid inhibition of chronic low-back pain influences degree of back pain relief after morphine administration.

Authors:  Stephen Bruehl; John W Burns; Rajnish Gupta; Asokumar Buvanendran; Melissa Chont; Erik Schuster; Christopher R France
Journal:  Reg Anesth Pain Med       Date:  2014 Mar-Apr       Impact factor: 6.288

4.  Effects of opioid blockade on nociceptive flexion reflex thresholds and nociceptive responding in hypertensive and normotensive individuals.

Authors:  Louisa Edwards; Christopher Ring; Christopher R France; David McIntyre; Una Martin
Journal:  Int J Psychophysiol       Date:  2008-03-15       Impact factor: 2.997

5.  What do plasma beta-endorphin levels reveal about endogenous opioid analgesic function?

Authors:  S Bruehl; J W Burns; O Y Chung; M Chont
Journal:  Eur J Pain       Date:  2011-12-19       Impact factor: 3.931

Review 6.  Neurobiological mechanisms of early life adversity, blunted stress reactivity and risk for addiction.

Authors:  Mustafa al'Absi; Annie T Ginty; William R Lovallo
Journal:  Neuropharmacology       Date:  2021-03-10       Impact factor: 5.273

Review 7.  Endogenous opioid antagonism in physiological experimental pain models: a systematic review.

Authors:  Mads U Werner; Manuel P Pereira; Lars Peter H Andersen; Jørgen B Dahl
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.